Cargando…
Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen
Tumor protein D52 (D52) is constitutively expressed in healthy tissues and overexpressed in multiple cancers, including (but not limited to) breast, prostate and ovarian carcinomas. Although the normal functions of D52 are unknown, it is clear that increased D52 expression levels not only stimulate...
Autores principales: | Bright, Jennifer D, Schultz, Heather N, Byrne, Jennifer A, Bright, Robert K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782160/ https://www.ncbi.nlm.nih.gov/pubmed/24073379 http://dx.doi.org/10.4161/onci.25049 |
Ejemplares similares
-
Overexpressed oncogenic tumor-self antigens: New vaccine targets
por: Bright, Robert K, et al.
Publicado: (2014) -
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype
por: Elizondo, C. Riccay, et al.
Publicado: (2022) -
In vitro models for tumor protein d52 function in cancer cells
por: Shehata, M, et al.
Publicado: (2005) -
Turning the tumor microenvironment into a self vaccine site
por: Nelson, Delia J.
Publicado: (2012) -
In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids
por: Galili, Uri
Publicado: (2013)